Treatment Response and Tolerability of Pegylated Interferon-α Plus Ribavirin Combination Therapy in elderly Patients (≥ 65 years) With Chronic Hepatitis C in Korea

BACKGROUND: The prevalence of hepatitis C virus (HCV) infections in elderly patients has been increasing in a number of countries. A few reports concerning pegylated interferon-α (PEG-IFN-α)-based combination treatment in elderly chronic hepatitis C (CHC) patients have been published, with slightly...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kim, Hyeong Il, Kim, In Hee, Jeon, Byung Jun, Lee, Seok, Kim, Seong Hun, Kim, Sang Wook, Lee, Seung Ok, Lee, Soo Teik, Kim, Dae Ghon
Formato: Artigo
Idioma:Inglês
Publicado: Kowsar 2012
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3437453/
https://ncbi.nlm.nih.gov/pubmed/23008722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.6170
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares